Page 730 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPtEr 51 Systemic Lupus Erythematosus 703

16. Wong M, Tsao BP. Current topics in human SLE genetics. Springer Semin 42. Cunningham M, Gilkeson G. Estrogen receptors in immunity and
Immunopathol 2006;28:97–107. autoimmunity. Clin Rev Allergy Immunol 2011;40:66–73.
17. Tucci M, Barnes EV, et al. Strong association of a functional 43. Mu Q, Zhang H, et al. SLE: Another autoimmune disorder influenced by
polymorphism in the monocyte chemoattractant protein 1 promoter microbes and diet? Front Immunol 2015;6:608.
gene with lupus nephritis. Arthritis Rheum 2004;50:1842–9. 44. Zoma A. Musculoskeletal involvement in systemic lupus erythematosus.
18. Crow MK. Interferon pathway activation in systemic lupus Lupus 2004;13:851–3.
erythematosus. Curr Rheumatol Rep 2005;7:463–8. 45. Urowitz MB, Gladman DD, et al. American College of Rheumatology
19. Nath SK, Harley JB, et al. Polymorphisms of complement receptor 1 and criteria at inception, and accrual over 5 years in the SLICC inception
interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. cohort. J Rheumatol 2014;41:875–80.
Hum Genet 2005;118:225–34. 46. Grossman JM. Lupus arthritis. Best Pract Res Clin Rheumatol
20. Schotte H, Willeke P, et al. Extended haplotype analysis reveals an 2009;23:495–506.
association of TNF polymorphisms with susceptibility to systemic lupus 47. Aranow C, Zelicof S, et al. Clinically occult avascular necrosis of the hip
erythematosus beyond HLA-DR3. Scand J Rheumatol 2005;34:114–21. in systemic lupus erythematosus. J Rheumatol 1997;24:2318–22.
21. Wu J, Metz C, et al. A novel polymorphic CAAT/enhancer-binding 48. Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus.
protein beta element in the FasL gene promoter alters Fas ligand Clin Dermatol 2004;22:121–4.
expression: a candidate background gene in African American systemic 49. Kirchhof MG, Dutz JP. The immunopathology of cutaneous lupus
lupus erythematosus patients. J Immunol 2003;170:132–8. erythematosus. Rheum Dis Clin North Am 2014;40:455–74, viii.
22. Mehrian R, Quismorio FP Jr, et al. Synergistic effect between IL-10 and 50. Orteu CH, Buchanan JA, et al. Systemic lupus erythematosus presenting
bcl-2 genotypes in determining susceptibility to systemic lupus with oral mucosal lesions: easily missed? Br J Dermatol 2001;144:1219–
erythematosus. Arthritis Rheum 1998;41:596–602. 23.
23. Ballestar E, Esteller M, et al. The epigenetic face of systemic lupus 51. Ebert EC, Hagspiel KD. Gastrointestinal and hepatic manifestations of
erythematosus. J Immunol 2006;176:7143–7. systemic lupus erythematosus. J Clin Gastroenterol 2011;45:436–41.
24. Chung SA, Nititham J, et al. Genome-wide assessment of differential 52. Yuan S, Ye Y, et al. Lupus mesenteric vasculitis: clinical features and
DNA methylation associated with autoantibody production in systemic associated factors for the recurrence and prognosis of disease. Semin
lupus erythematosus. PLoS ONE 2015;10:e0129813. Arthritis Rheum 2014;43:759–66.
25. Javierre BM, Fernandez AF, et al. Changes in the pattern of DNA 53. Zhang L, Xu D, et al. Clinical features, morbidity, and risk factors of
methylation associate with twin discordance in systemic lupus intestinal pseudo-obstruction in systemic lupus erythematosus: a
erythematosus. Genome Res 2010;20:170–9. retrospective case-control study. J Rheumatol 2016;43:559–64.
26. Jeffries MA, Sawalha AH. Epigenetics in systemic lupus erythematosus: 54. Mackay IR. Historical reflections on autoimmune hepatitis. World J
leading the way for specific therapeutic agents. Int J Clin Rheumatol Gastroenterol 2008;14:3292–300.
2011;6:423–39. 55. Mittoo S, Fell CD. Pulmonary manifestations of systemic lupus
27. Watad A, Neumann SG, et al. Vitamin D and systemic lupus erythematosus. Semin Respir Crit Care Med 2014;35:249–54.
erythematosus: myth or reality? Isr Med Assoc J 2016;18:177–82. 56. Miner JJ, Kim AH. Cardiac manifestations of systemic lupus
28. Milner EC, Anolik J, et al. Human innate B cells: a link between host erythematosus. Rheum Dis Clin North Am 2014;40:51–60.
defense and autoimmunity? Springer Semin Immunopathol 57. Manzi S, Meilahn EN, et al. Age-specific incidence rates of myocardial
2005;26:433–52. infarction and angina in women with systemic lupus erythematosus:
29. Pugh-Bernard AE, Cambier JC. B cell receptor signaling in human comparison with the Framingham Study. Am J Epidemiol
systemic lupus erythematosus. Curr Opin Rheumatol 2006;18:451–5. 1997;145:408–15.
30. Liu Z, Davidson A. BAFF and selection of autoreactive B cells. Trends 58. Sesin CA, Yin X, et al. Shedding of endothelial protein C receptor
Immunol 2011;32:388–94. contributes to vasculopathy and renal injury in lupus: in vivo and in vitro
31. Grimaldi CM, Hill L, et al. Hormonal modulation of B cell development evidence. Kidney Int 2005;68:110–20.
and repertoire selection. Mol Immunol 2005;42:811–20. 59. Weening JJ, D’Agati VD, et al. The classification of glomerulonephritis in
32. Doreau A, Belot A, et al. Interleukin 17 acts in synergy with B systemic lupus erythematosus revisited. J Am Soc Nephrol
cell-activating factor to influence B cell biology and the pathophysiology 2004;15:241–50.
of systemic lupus erythematosus. Nat Immunol 2009;10:778–85. 60. Davidson A, Aranow C. Lupus nephritis: lessons from murine models.
33. Lande R, Ganguly D, et al. Neutrophils activate plasmacytoid dendritic Nat Rev Rheumatol 2010;6:13–20.
cells by releasing self-DNA-peptide complexes in systemic lupus 61. Newman K, Owlia MB, et al. Management of immune cytopenias in
erythematosus. Sci Transl Med 2011;3:73ra19. patients with systemic lupus erythematosus—old and new. Autoimmun
34. Garcia-Romo GS, Caielli S, et al. Netting neutrophils are major inducers Rev 2013;12:784–91.
of type I IFN production in pediatric systemic lupus erythematosus. Sci 62. Gonzalez-Naranjo LA, Betancur OM, et al. Features associated with
Transl Med 2011;3:73ra20. hematologic abnormalities and their impact in patients with systemic
35. Bennett L, Palucka AK, et al. Interferon and granulopoiesis signatures in lupus erythematosus: Data from a multiethnic Latin American cohort.
systemic lupus erythematosus blood. J Exp Med 2003;197:711–23. Semin Arthritis Rheum 2016;45:675–83.
36. Kis-Toth K, Tsokos GC. Dendritic cell function in lupus: independent 63. Sultan SM, Begum S, et al. Prevalence, patterns of disease and
contributors or victims of aberrant immune regulation. Autoimmunity outcome in patients with systemic lupus erythematosus who develop
2010;43:121–30. severe haematological problems. Rheumatology (Oxford) 2003;42:
37. Crispin JC, Kyttaris VC, et al. T cells as therapeutic targets in SLE. Nat 230–4.
Rev Rheumatol 2010;6:317–25. 64. Carli L, Tani C, et al. Leukopenia, lymphopenia, and neutropenia in
38. Scheinecker C, Bonelli M, et al. Pathogenetic aspects of systemic lupus systemic lupus erythematosus: Prevalence and clinical impact—A
erythematosus with an emphasis on regulatory T cells. J Autoimmun systematic literature review. Semin Arthritis Rheum 2015;45:190–4.
2010;35:269–75. 65. Matsuyama W, Yamamoto M, et al. TNF-related apoptosis-inducing
39. Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. ligand is involved in neutropenia of systemic lupus erythematosus. Blood
Eur J Immunol 2015;45:344–55. 2004;104:184–91.
40. McMurray RW. Bromocriptine in rheumatic and autoimmune diseases. 66. Michel M, Lee K, et al. Platelet autoantibodies and lupus-associated
Semin Arthritis Rheum 2001;31:21–32. thrombocytopenia. Br J Haematol 2002;119:354–8.
41. Zhang W, Wu K, et al. Transforming growth factor beta 1 plays an 67. Mackay M. Lupus brain fog: a biologic perspective on cognitive
important role in inducing CD4(+)CD25(+)forhead box P3(+) regulatory impairment, depression, and fatigue in systemic lupus erythematosus.
T cells by mast cells. Clin Exp Immunol 2010;161:490–6. Immunol Res 2015;63:26–37.